A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care.,JAMA Internal Medicine

当前位置： X-MOL 学术 › JAMA Intern. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care.
JAMA Internal Medicine ( IF 22.5 ) Pub Date : 2020-04-01 , DOI: 10.1001/jamainternmed.2019.6770
Ashleigh C King ₁ , Lisa M Schwartz ₁ , Steven Woloshin _{1,

2}

Affiliation

Pharmaceutical companies spend more on clinician office visits (also known as detailing) and free drug samples (also known as sample closets) than any other forms of professional marketing in the United States (totaling $18.5 billion in 2016).¹ Detailing and free samples affect prescribing quality and expenditures, often by promoting new and expensive brand-name drugs over equally effective, older, and less expensive options.² Some hospitals and medical centers have restricted these activities.³ We surveyed a national sample of US outpatient practices delivering primary care to determine the prevalence of detailing and sample closets.

中文翻译：

全国范围内对药品公司详细拜访和免费提供样品间的频率的调查，以提供基本医疗服务。

与美国任何其他形式的专业营销（2016年总计185亿美元）相比，制药公司在临床医生上门拜访（也称为``详细信息''）和免费药物样本（也称为``样本壁橱''）上的支出更多。¹详细信息和免费样品会影响处方质量和费用，通常是通过推广新的和昂贵的名牌药品，而不是同样有效，较旧且价格较低的选择。²一些医院和医疗中心限制了这些活动。³我们调查了提供门诊服务的美国门诊实践的全国样本，以确定细节和壁橱的普遍程度。

更新日期：2020-04-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11